Investigations of a 99mTc-labeled bacteriophage as a potential infection-specific imaging agent

Journal of Nuclear Medicine

Volumn 45, Issue 7, 2004, Pages 1201-1208

  Rusckowski, Mary ^a,b   Gupta, Suresh ^a   Liu, Guozheng ^a   Dou, Shuping ^a   Hnatowich, Donald J ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

99mTc bacteriophage; Bacterial infection; Infection imaging

Indexed keywords

MERTIATIDE TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIOPHAGE; CONTROLLED STUDY; ESCHERICHIA COLI; IN VIVO STUDY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; STAPHYLOCOCCUS AUREUS; THIN LAYER CHROMATOGRAPHY; ANIMAL; BACTERIOPHAGE M13; ENTEROBACTER INFECTION; EVALUATION; ISOLATION AND PURIFICATION; ISOTOPE LABELING; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; MYOSITIS; PHYSIOLOGY; SCINTISCANNING; TISSUE DISTRIBUTION; VIROLOGY;

ANIMALS; BACTERIOPHAGE M13; ESCHERICHIA COLI INFECTIONS; ISOTOPE LABELING; METABOLIC CLEARANCE RATE; MICE; MYOSITIS; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M MERTIATIDE; TISSUE DISTRIBUTION;

EID: 4043111339     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Rubin RH, Young LS, Hansen WP, et al. Specific and nonspecific imaging of localized Fisher immunotype 1 Pseudomonas aeruginosa infection with radiolabeled monoclonal antibody. J Nucl Med. 1988;29:651-656.
2. Vinjamuri S, Hall A, Britton KE. Tc99m Infecton, a bacterial specific infection imaging agent [abstract]. Eur J Nucl Med. 1995;22:916.
3. 99mTc Infecton imaging with radiolabeled white-cell imaging in the evaluation of bacterial infection. Lancet. 1996;347:233-235.
4. Britton KE, Vinjamuri S, Hall AV, et al. Clinical evaluation of technetium-99m Infecton for the localization of bacterial infection. Eur J Nucl Med. 1997;24:553-556.
5. 99mTc-Infecton, a novel agent for detecting sites of infection. J Clin Pathol. 1998;51:215-219.
6. Nibbering PH, Welling M, Van Den Broek, Pauwels EKJ. Radiolabeled antimicrobial peptides for imaging of infections: a review. Nucl Med Commun. 1998;19:1117-1121.
7. Welling M, Paulusma-Annema M, Balter HS, Pauwels EKJ, Nibbering PH. Technetium-99m labeled antimicrobial peptides discriminate between bacterial infections and sterile inflammations. Eur J Nucl Med. 2000;27:292-301.
8. 99mTc-UBI 29-41 for imaging of bacterial infections. Nucl Med Biol. 2002;29:413-422.
9. d'Herelle F. The Bacteriophage: Its Role in Immunity. Smith GH, trans. Baltimore, MD: Williams and Wilkins Co./Waverly Press; 1922.
10. Merril CR, Scholl D, Adhya SL. The prospect for bacteriophage therapy in Western medicine. Nat Rev Drug Discov. 2003;2:489-497.
11. 3 technetium-99m labeling of DNA. Nucl Med Biol. 1997;24:425-432.
12. PhD-12 Phage Display Peptide Library Kit. In: New England Biolabs Manual. Version 2.5. Beverly, MA: New England Biolabs, Inc.; 1999:1-23.
13. Smith GP, Scott JK. Libraries of peptides and proteins displayed on filamentous phage. Meth Enzymol. 1993;217:228-257.
14. 3 bifunctional chelator. J Nucl Med. 1998;39:56-64.
15. Brock TD. Biology of Microorganisms. Englewood Cliffs, NJ: Prentice-Hall Inc.; 1970:206.
16. Lavender JP, Lowe J, Barker JR, Burn JL, Chaudhri MA. Gallium-67 citrate scanning in neoplastic and inflammatory lesions. Br J Radiol. 1971;44:361-366.
17. 67Ga localization in malignant disease. Nucl Med Biol. 1996;23:745-751.
18. McAfee JG, Thakur ML. Survey of radioactive agents for the in vitro labeling of phagocytic leucocytes. I. Soluble agents. J Nucl Med. 1976;17:480-487.
19. McAfee JG, Thakur ML. Survey of radioactive agents for the in vitro labeling of phagocytic leucocytes. II. Particles. J Nucl Med. 1976;17:488-492.
20. 99mTc hexamethylpropylene-amineoxime for labeling leucocytes and imaging infection. Lancet. 1986;2:945-949.
21. 99mTc-interleukin-2: a new radiopharmaceutical for in vivo detection of activated lymphocytes [abstract]. Eur J Nucl Med. 1994;21:807.
22. Oyen WJG, Boerman OC, Storm G, et al. Detecting infection and inflammation with technetium-99m-labeled stealth liposomes. J Nucl Med. 1996;37:1392-1397.
23. Fischman AJ, Pike MC, Kroon D, et al. Imaging focal sites of bacterial infection in rats with indium-111-labeled chemotactic peptide analogs. J Nucl Med. 1991;32:483-491.
24. 99mTc-neutrophil elastase inhibitor in monkeys. J Nucl Med. 2000;41:363-374.
25. Rusckowski M, Fritz B, Hnatowich DJ. Localization of infection using streptavidin and biotin: an alternative to nonspecific polyclonal immunoglobulin. J Nucl Med. 1992;33:1810-1815.
26. 111In-labeled biotin. J Nucl Med. 1999;40:484-490.
27. Merril CR, Biswas B, Carlton R, et al. Long-circulating bacteriophage as antibacterial agents. Proc Natl Acad Sci. 1996;93:3188-3192.
28. Ackermann HW, DuBow MS. General Properties of Bacteriophages. Boca Raton, FL: CRC Press; 1987:146. Virus of Procaryotes; vol 1.
29. Inchley CJ. The activity of mouse Kupffer cells following intravenous injection of T4 bacteriophage. Clin Exp Immunol. 1969;5:173-187.
30. Geier MR, Trigg ME, Merril CR. Fate of bacteriophage lambda in non-immune germ-free mice. Nature. 1973;246:221-222.